Skip to main content
. 2017 Apr 20;8(32):52527–52542. doi: 10.18632/oncotarget.17283

Figure 9. EGFL7, ERK, P-ERK, VEGF, and CD31 protein expressions in smmc-7721, Bet-7402 and HepG2 cell lines in vivo.

Figure 9

(A). EGFL7, ERK, P-ERK, VEGF, and CD31 protein expression in HepG2 cells in vivo; (B). EGFL7, ERK, P-ERK, VEGF, and CD31 protein expression in Bet-7402 cells in vivo; (C). EGFL7, ERK, P-ERK, VEGF and CD31 protein expression in smmc-7721 cells in vivo; *P < 0.05 compared with the blank group; miR-126, microRNA-126; EGFL7, epidermal growth factor-like domain 7; ERK, extracellular signal-regulated kinase; P-ERK, phosphorylated ERK; VEGF, vascular endothelial growth factor.